In an action filed by certain patients of the pharmacy as Relators under the federal False Claims Act (the “FCA”), the Relators contended, on behalf of the United States, that the pharmacy violated the FCA by submitting claims to United States Department of Labor (“DOL”) for a non-controlled compound supplement, that were either not ordered by a licensed provider or not delivered to the beneficiary.
Sisco-Law, in conjunction with New Jersey co-counsel with Mandelbaum Barrett’s Healthcare and White Collar/Governmental Investigations Practice Groups, defended the action by presenting exculpating evidence to the government to support the propriety of the pharmacy’s billing practices. As a result, the pharmacy reached an amicable False Claims Act settlement with the government on favorable terms.
